Followed up infants until 18 months of age with neurologic, visual, auditory, and neurodevelopmental assessments by a developmental specialist using the Bayley II scale. No differences were ...

Bayley Scales of Infant Development II-R [mental developmental index (MDI), psychomotor developmental index (PDI)], the Palisano Gross Motor Function examination, structured interviews ...

Ionis Pharmaceuticals has announced the design for a pivotal Phase III trial of ION582, an investigational treatment for AS, ...

All of the children treated with Evrysdi who had three or more SMN2 copies (n=18), achieved standing and walking (100%) milestones as assessed by Bayley Scales of Infant and Toddler Development ...

In this study, a nonclinical sample of 62 parents of children aged 2–3 years was assessed for knowledge of child development processes and milestones [using the Knowledge of Infant Development ...

Human infants have limited motor capabilities, which prevents them from accessing and exploring all parts of their ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the pivotal Phase 3 study design following successful alignment with the U.S. Food and Drug Administration (FDA) on ION582, an ...

When former WWE NXT Women's Champion Bayley first debuted in "WWE NXT," she was a lovable, huggable wrestler with her own set of "Bayley Buddies," which inflated upon her entrance. Bayley ...

Roche’s spinal muscular atrophy (SMA) drug Evrysdi (risdiplam) has helped pre-symptomatic babies reach rare milestones after two years of treatment in a Phase II trial. The Rainbowfish trial ...

Bayley was part of WWE's recent tour to the ... We got a little taste of it then, but it's so different now where it's on a much larger scale, and somehow he still makes time for everybody.

All of the children treated with Evrysdi who had three or more SMN2 copies (n=18), achieved standing and walking (100%) milestones as assessed by Bayley Scales of Infant and Toddler Development, third ...